206 related articles for article (PubMed ID: 18182989)
1. Effects of adiponectin on breast cancer cell growth and signaling.
Grossmann ME; Nkhata KJ; Mizuno NK; Ray A; Cleary MP
Br J Cancer; 2008 Jan; 98(2):370-9. PubMed ID: 18182989
[TBL] [Abstract][Full Text] [Related]
2. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
4. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.
Tang CK; Concepcion XZ; Milan M; Gong X; Montgomery E; Lippman ME
Cancer Res; 1999 Oct; 59(20):5315-22. PubMed ID: 10537315
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol.
Pfeiler GH; Buechler C; Neumeier M; Schäffler A; Schmitz G; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):787-93. PubMed ID: 18288417
[TBL] [Abstract][Full Text] [Related]
9. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
10. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
11. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
Chung H; Jung YM; Shin DH; Lee JY; Oh MY; Kim HJ; Jang KS; Jeon SJ; Son KH; Kong G
Int J Cancer; 2008 Feb; 122(4):816-22. PubMed ID: 17957784
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
15. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
16. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Nukatsuka M; Saito H; Nakagawa F; Abe M; Uchida J; Shibata J; Matsuo K; Noguchi S; Kiniwa M
Breast Cancer Res Treat; 2011 Jul; 128(2):381-90. PubMed ID: 20809360
[TBL] [Abstract][Full Text] [Related]
17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells.
Dos Santos E; Benaitreau D; Dieudonne MN; Leneveu MC; Serazin V; Giudicelli Y; Pecquery R
Oncol Rep; 2008 Oct; 20(4):971-7. PubMed ID: 18813842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
